TCL Archive First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive November 27, 1987
TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds. December 14, 2001
